TrialBlood advances2026
FLT3-ITD measurable residual disease from the QuANTUM-First trial.
Mark J Levis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it
TrialBlood advances2026
Mark J Levis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.